ArticleScientific reports2023
A performance evaluation of drug response prediction models for individual drugs.
Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 40 citations in OpenAlex.
- Predicting gene essentiality and drug response from preclinical perturbation screens with layered ensemble of autoencoders and predictors.Scientific reports · 2026Article
- Monotherapy cancer drug-blind response prediction is limited to intraclass generalization.PLoS computational biology · 2026Article
- BKDRP: a biological knowledge-driven approach for drug response prediction using multi-omics data in cancer cell lines.BMC bioinformatics · 2026Article
- QAL333's antitumor activity and predictive modeling: integrated transcriptomic-bioinformatic analysis reveals selective cytotoxicity and sensitivity determinants.Scientific reports · 2026Article
- Exploiting artificial intelligence in precision oncology: an updated comprehensive review.Journal of translational medicine · 2025Review
- Current AI technologies in cancer diagnostics and treatment.Molecular cancer · 2025Review
- Applications of AI in Predicting Drug Responses for Type 2 Diabetes.JMIR diabetes · 2025Article
- The Hallmarks of Predictive Oncology.Cancer discovery · 2025Article
- A guide for active learning in synergistic drug discovery.Scientific reports · 2025Article
- Drug response in the era of precision medicine: A methodological review.Computational and structural biotechnology journal · 2025Review
- Demystifying the black box: A survey on explainable artificial intelligence (XAI) in bioinformatics.Computational and structural biotechnology journal · 2025Review
- An Innovative Multi-Omics Model Integrating Latent Alignment and Attention Mechanism for Drug Response Prediction.Journal of personalized medicine · 2024Article
- Predicting drug response through tumor deconvolution by cancer cell lines.Patterns (New York, N.Y.) · 2024Article
- Optimized models and deep learning methods for drug response prediction in cancer treatments: a review.PeerJ. Computer science · 2024Article
- Machine learning in onco-pharmacogenomics: a path to precision medicine with many challenges.Frontiers in pharmacology · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Drug response prediction is important to establish personalized medicine for cancer therapy. Model construction for predicting drug response (i.e., cell viability half-maximal inhibitory concentration [IC
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.